Riskpilot← Back to searchSign inGet full accessÅlstenstandläkarna AB
ABActiveOrg 5569857674Ålstensgatan 14Dental practice care activities · NACE 8623Est. 20140 employees
Revenue 2024
SEK 4,1M
-52% vs 2023
EBITDA margin
64.3%
+24% vs 2023
Equity ratio
44.5%
Financial strength
Net profit 2024
SEK 1,7M
+24% vs 2023
| Revenue | SEK 4,1M | -52% |
| EBITDA | SEK 2,7M | +24% |
| Net profit | SEK 1,7M | +24% |
| Total assets | SEK 7,5M | +1% |
| Equity | SEK 3,3M | +24% |
| Employees | 0 | — |
Legal name
Ålstenstandläkarna AB
Org number
5569857674
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
9 oktober 2014
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva tandvård, utbildning och konsultverksamhet inom detta område, äga och förvalta fast och lös egendom och värdepapper samt idka därmed förenlig verksamhet.
Address
Ålstensgatan 14
Phone
+468262102
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 133 | 8 384 | 8 078 | 8 571 | 4 122 |
| Staff expenses | — | — | — | — | −2 331 |
| EBITDA | 2 294 | 2 963 | 2 692 | 2 138 | 2 650 |
| Depreciation & amort. | −486 | −407 | −402 | −541 | −332 |
| EBIT | 1 808 | 2 556 | 2 290 | 1 597 | 2 318 |
| Net financials | −77 | 529 | −894 | 74 | 192 |
| Profit before tax | 1 345 | 3 131 | 1 308 | 1 692 | 2 107 |
| Tax | −295 | −651 | −396 | −336 | −430 |
| Net profit | 1 050 | 2 480 | 912 | 1 356 | 1 676 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 842 | 4 679 | 7 509 | 7 411 | 7 496 |
| Equity | 1 101 | 2 531 | 2 227 | 2 683 | 3 337 |
| Long-term debt | 2 550 | 0 | 2 000 | 2 000 | 0 |
| Short-term debt | 878 | 882 | 1 518 | 985 | 2 013 |
| Total debt | 3 428 | 882 | 3 518 | 2 985 | 2 013 |
EBITDA margin
64.3%
This company
15.8%
Market median
+307% vs market
20202024
Equity ratio
44.5%
This company
38.2%
Market median
+16% vs market
20202024
Return on equity
50.2%
This company
18.4%
Market median
+173% vs market
20202024
Net profit margin
40.7%
This company
8.1%
Market median
+402% vs market
20202024
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
20202024
Debt / equity
1.25×
This company
0.62×
Market median
-102% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
IM | Audit | 2022 |
PE Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ålstenstandläkarna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Irma Margaretha Morén | Audit | 0 companies |
| Per Erik From | Chief Executive Officer | 0 companies |
| Ann Cecilia From | Deputy Board Member | 0 companies |